Using UNC's expertise to fight emerging diseases
Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that.
(UNC.edu)
Related: Campus Connections
UNC Alum, NASA Astronaut Zena Cardman Captures Incredible Visual Of Aurora From SpaceUNC alumna Zena Cardman serves as the commander of NASA's SpaceX Crew-11 mission, which was launched on August 1, 2025. At the International Space Station,...
Fri Dec 5, 2025What does it take to open a restaurant on Franklin Street?
Kenan-Flagler Business School professor Dr. Ted Zoller said restaurant culture in Chapel Hill manifests in the East Franklin Street and West Franklin Street markets, which...
Wed Dec 3, 2025
UNC professor Kathleen DuVal shares expertise in Ken Burns documentary ‘The American Revolution’
Kathleen DuVal’s American Revolution course at UNC enrolls around 150 students, but last week she shared history lessons with a few additional people — millions...
Wed Dec 3, 2025
'Epitomized the Carolina Spirit': UNC remembers Eve Carson on her 40th birthday
Eve Carson, former student body president and Morehead-Cain scholar, was killed during the spring semester of her senior year at UNC. In 2007, as a...
Sat Nov 29, 2025